文献速递免疫规划卫生政策与健康促进

HIV人群水平适应可迅速削弱部分有效疫苗的影响

HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine.
PubMed 文献 · Vaccine · 2017-12-11

研究使用两个HIV流行模型模拟大规模疫苗接种项目,并纳入HIV毒株对疫苗反应的多样性,发现人群水平的病毒快速适应可降低整体疫苗效力并大幅减少接种所避免的感染数。以南非流行为例,在70%接种覆盖率下,接种推广10年内可能因HIV适应而出现25万例未被疫苗避免的感染。

要点

  • 人群水平HIV快速适应可降低整体疫苗效力并减少接种避免的感染数。
  • 模拟显示南非70%接种覆盖率下10年内因HIV适应出现25万例未避免感染。
  • HIV疫苗开发、项目实施和流行建模可能需关注病毒对接种的适应。

核心结论

  • 人群水平病毒快速适应可导致整体疫苗效力下降并大幅减少接种所避免的感染数。
  • 南非70%接种覆盖率下接种推广10年内可能因HIV适应出现25万例未被疫苗避免的感染。
  • HIV疫苗开发、项目实施和流行建模可能需关注病毒对接种的适应。

研究设计与样本

  • 使用两个HIV流行模型模拟大规模疫苗接种项目,并纳入HIV毒株对疫苗反应的多样性。
  • 模拟比较有与无病毒演化的情景,结果取决于接种覆盖率、疫苗对敏感等位基因的效力和初始耐药等位基因频率。

主要发现

  • 人群水平病毒快速适应可导致整体疫苗效力下降并大幅减少接种所避免的感染数。
  • 南非70%接种覆盖率情景下,接种推广10年内可能因HIV适应出现25万例未被疫苗避免的感染,其他条件相同。

关键数值与推荐

  • 南非情景下70%接种覆盖率可能因HIV适应在接种推广10年内出现25万例未被疫苗避免的感染。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Development of an HIV vaccine might be essential to ending the HIV/AIDS pandemic. However, vaccines can result in the emergence and spread of vaccine-resistant strains. Indeed, analyses of breakthrough infections in the HIV phase 3 vaccine trial RV144 identified HIV genotypes with differential rates of transmission in vaccine and placebo recipients. We hypothesized that, for HIV vaccination programs based on partially effective vaccines similar to RV144, HIV adaptation will rapidly diminish the expected vaccine impact. METHODS AND FINDINGS: Using two HIV epidemic models, we simulated large-scale vaccination programs and, critically, included HIV strain diversity with respect to the vaccine response. We show here that rapid population-level viral adaptation can lead to decreased overall vaccine efficacy and substantially fewer infections averted by vaccination, when comparing scenarios with and without viral evolution (with outcomes depending on vaccination coverage, vaccine efficacy against the sensitive allele, and the initial resistant allele frequency). Translating this to the epidemic in South Africa, a scenario with 70% vaccination coverage may result in 250,000 infections (non-averted by vaccination) within 10 years of vaccine rollout that are due solely to HIV adaptation, all else being equal. CONCLUSIONS: These findings suggest that approaches to HIV vaccine development, program implementation, and epidemic modeling may require attention to viral adaptation in response to vaccination.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Herbeck JT, Peebles K, Edlefsen PT, et al. HIV population-level adaptation can rapidly diminish the impact of a partially effective vaccine. Vaccine. 2017. PMID: 29241646. doi:10.1016/j.vaccine.2017.12.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。